Trial Profile
The Role of COMT (Catechol-O-Methyltransferase) Inhibition in Treating Non-Motor Fluctuations in Parkinsons Disease
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2016
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 01 Jul 2016 New trial record